BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30580464)

  • 1. Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study.
    Fenton GL; Smit AK; Keogh L; Cust AE
    Br J Dermatol; 2019 Jun; 180(6):1390-1396. PubMed ID: 30580464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?
    Smit AK; Keogh LA; Newson AJ; Butow PN; Dunlop K; Morton RL; Kirk J; Espinoza D; Cust AE
    Br J Dermatol; 2017 Sep; 177(3):779-790. PubMed ID: 28627002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.
    Smit AK; Keogh LA; Newson AJ; Hersch J; Butow P; Cust AE
    Public Health Genomics; 2015; 18(5):309-17. PubMed ID: 26390062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
    Smit AK; Espinoza D; Newson AJ; Morton RL; Fenton G; Freeman L; Dunlop K; Butow PN; Law MH; Kimlin MG; Keogh LA; Dobbinson SJ; Kirk J; Kanetsky PA; Mann GJ; Cust AE
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):212-221. PubMed ID: 27702805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
    Smit AK; Newson AJ; Morton RL; Kimlin M; Keogh L; Law MH; Kirk J; Dobbinson S; Kanetsky PA; Fenton G; Allen M; Butow P; Dunlop K; Trevena L; Lo S; Savard J; Dawkins H; Wordsworth S; Jenkins M; Mann GJ; Cust AE
    Contemp Clin Trials; 2018 Jul; 70():106-116. PubMed ID: 29802966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
    Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
    Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.
    Smit AK; Newson AJ; Best M; Badcock CA; Butow PN; Kirk J; Dunlop K; Fenton G; Cust AE
    Eur J Hum Genet; 2018 Aug; 26(8):1094-1100. PubMed ID: 29706632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma.
    Bränström R; Kasparian NA; Affleck P; Tibben A; Chang YM; Azizi E; Baron-Epel O; Bergman W; Chan M; Davies J; Ingvar C; Kanetsky PA; van Leeuwen E; Olsson H; Gruis NA; Brandberg Y; Newton-Bishop J
    Eur J Cancer; 2012 Nov; 48(16):3052-62. PubMed ID: 22726816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public preferences for communicating personal genomic risk information: a focus group study.
    Smit AK; Keogh LA; Hersch J; Newson AJ; Butow P; Williams G; Cust AE
    Health Expect; 2016 Dec; 19(6):1203-1214. PubMed ID: 26332492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation considerations for offering personal genomic risk information to the public: a qualitative study.
    Smit AK; Reyes-Marcelino G; Keogh L; Dunlop K; Newson AJ; Cust AE
    BMC Public Health; 2020 Jun; 20(1):1028. PubMed ID: 32600382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.
    Lo SN; Smit AK; Espinoza D; Cust AE;
    Trials; 2020 Jun; 21(1):594. PubMed ID: 32605576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
    Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
    Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective.
    Kasparian NA; Butow PN; Meiser B; Mann GJ
    Psychooncology; 2008 Mar; 17(3):270-9. PubMed ID: 17600854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary melanoma and predictive genetic testing: why not?
    Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
    Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.
    Hay JL; Berwick M; Zielaskowski K; White KA; Rodríguez VM; Robers E; Guest DD; Sussman A; Talamantes Y; Schwartz MR; Greb J; Bigney J; Kaphingst KA; Hunley K; Buller DB
    JMIR Res Protoc; 2017 Apr; 6(4):e52. PubMed ID: 28442450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.
    Fenton GL; Smit AK; Freeman L; Badcock C; Dunlop K; Butow PN; Kirk J; Cust AE
    J Genet Couns; 2018 Apr; 27(2):370-380. PubMed ID: 29199389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers.
    Tan JD; Butow PN; Boyle FM; Saw RP; O'Reilly AJ
    Melanoma Res; 2014 Jun; 24(3):252-60. PubMed ID: 24584097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
    Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
    Psychooncology; 2013 Feb; 22(2):276-89. PubMed ID: 23382133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.
    Kasparian NA; Meiser B; Butow PN; Soames Job RF; Mann GJ
    Psychooncology; 2007 Jan; 16(1):69-78. PubMed ID: 16874747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress.
    Stump TK; Aspinwall LG; Kohlmann W; Champine M; Hauglid J; Wu YP; Scott E; Cassidy P; Leachman SA
    J Genet Couns; 2018 Aug; 27(4):955-967. PubMed ID: 29349527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.